The $39 central target reflects eight individual analyst price targets verified across recent research. The calculated mean of those targets is $38.50, rounded to $39 for readability. The range spans $25 (Barclays, Sell) to $47 (Jefferies, Buy), a roughly 88% gap between the most and least optimistic views that underscores how divided the Street has become. On the bullish side, Copart draws Buy or Outperform ratings from Baird ($38), J.P. Morgan ($40), Barrington ($40), Freedom Capital Markets ($39), BNP Paribas ($43), and Jefferies ($47). HSBC moved to the sidelines with a Hold and a $36 target, while Barclays' $25 Sell rating stands out as a notable dissenter. Recent action has been mixed: BNP Paribas raised its target in late September, but Baird lowered its target from $42 to $38 in October, and Barclays reiterated its bearish stance into November. Analysts broadly agree on the fundamentals — dominant market position, high margins, and a debt-light balance sheet — but disagree sharply on whether the decline in U.S. insurance volumes is cyclical or structural, which is why the spread between targets is so wide. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
With shares near $31, reaching $39 implies upside of about 26%. By conventional standards, that qualifies as a substantial move — achievable only with a meaningful improvement in the volume narrative, not just steady-state performance. Copart's market capitalization is roughly $28.6 billion, with trailing earnings per share (EPS) around $1.55 and a price-to-earnings (P/E) ratio near 20. The path toward $39 would likely require stabilization and eventual recovery in U.S. insurance assignment volumes. Copart has reported three consecutive quarters of declining U.S. insurance units excluding catastrophe events, driven by elevated auto-insurance premiums that prompted policyholders to reduce coverage and report fewer claims. Offsetting this, higher average selling prices and international expansion have kept revenue roughly flat. A sustained rebound in units — or faster-than-expected contribution from the newly acquired ACV platform — would be the clearest route toward the target.
Copart's 52-week range spans roughly $25.72 to $41.79, placing the stock near the lower-middle of that band after a rebound from the November low. The 50-day moving average sits near $29.45 while the 200-day average is around $32.22, meaning the stock remains below its longer-term trend line — a sign that the recovery is not yet confirmed. The $40 area, just above the target, aligns with prior resistance and a psychological round-number level, while $25.72 marks the key support that has so far held. From what I see, the technical setup suggests the stock needs a clear break above the 200-day average to build momentum.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms vary. The next major catalyst is Copart's first-quarter fiscal 2027 results, scheduled for release on December 1, 2026. Investors should watch U.S. insurance unit trends, average selling prices, commentary on the ACV integration, and any analyst target revisions that follow. Broader signals — auto-insurance pricing, total-loss frequency, and new-car affordability — will also shape whether the volume headwind fades. I’m watching this closely ahead of the earnings release.
In my view, layering an automated perspective on top of the fundamentals can help clarify the picture. Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and identify changing trends more efficiently than manual screening allows. For those following names like CPRT, it offers a data-driven complement to fundamental research. One thing that stands out is how these signals can flag shifts in momentum that align with the volume trends discussed earlier.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CPRT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 18, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 40 instances where the indicator turned negative. In 27 of the 40 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 68%.
The 10-day RSI Indicator for CPRT moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 19 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 59 cases where CPRT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 64%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CPRT as a result. In 49 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPRT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
CPRT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
CPRT moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CPRT crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 63%.
Following a +8.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPRT advanced for three days, in 179 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Aroon Indicator entered an Uptrend today. In 112 of 224 cases where CPRT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 50%.
The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. CPRT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.251) is normal, around the industry mean (5.887). P/E Ratio (20.481) is within average values for comparable stocks, (33.618). Projected Growth (PEG Ratio) (2.678) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (6.321) is also within normal values, averaging (9.907).
The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CPRT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of online auctions and vehicle remarketing services
Industry OfficeEquipmentSupplies